After raising $1 billion for Knight Cancer Institute, the Oregon Health and Science University fundraising team set out to raise another $1 billion over five years—before 2020.
THE DR. RALPH AND MARIAN FALK MEDICAL RESEARCH TRUST awarded $485,000 to research teams from the Icahn School of Medicine at Mount Sinai and Thomas Jefferson University in Philadelphia to study the effects of key genetic mutations in uveal melanoma. There are no FDA-approved therapies for metastatic UM and patient survival is poor. Julio Aguirre-Ghiso,... […]
THE AMERICAN BRAIN TUMOR ASSOCIATION awarded 16 grants to support brain tumor research. This year’s funded projects focus on areas such as potential new therapies, novel imaging approaches, immunotherapy and metastatic disease. The American Brain Tumor Association Discovery Grant is a one-year, $50,000 grant supporting approaches that have the potential to change current diagnostic or... […]
SHIRLEY JOHNSON was named senior vice president of Nursing & Patient Care Services and chief nursing officer of the Roswell Park Cancer Institute. Johnson was most recently senior vice president and Chief Nursing and Patient Care Services Officer at City of Hope. She has been recognized with the American College of Surgeons Commission on Cancer... […]
COLUMBIA UNIVERSITY and New York-Presbyterian said that their shared medical campus in Washington Heights will now be called Columbia University Herbert and Florence Irving Medical Center and NewYork-Presbyterian/Columbia University Irving Medical Center for donors Herbert and Florence Irving. The Irvings’ donations and commitments over time to Columbia University Medical Center and NewYork-Presbyterian will exceed $300... […]
THE CANCER PROGRESS REPORT released by the American Association for Cancer Research argues that although funded research continues to spur progress against cancer, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for NIH, NCI, and FDA.
SPECTRUM PHARMACEUTICALS INC. is under investigation by national securities law firm Faruqi & Faruqi LLP for potential securities fraud. The firm said it’s investigating whether the company and its executives violated federal securities laws by issuing materially misleading information about the company. Specifically, on Sept. 14, the FDA Oncologic Drugs Advisory Committee (ODAC) voted against... […]
REP. MICHAEL BURGESS (R-TX) received the American Society of Clinical Oncology‘s first-ever ASCO Congressional Leadership Award for his work to support policies related to cancer research and treatment. The new, annual award honors a member of Congress who is a consistent champion for patients and survivors of cancer, their families, and health care teams. Burgess... […]
90 CANCER GROUPS AND CANCER CENTERS, in a sign-on letter, urged the Center for Medicare & Medicaid Services to rescind proposed reimbursement cuts for lung cancer screening in its proposed rule on the 2017 Hospital Outpatient Prospective Payment System. The proposal lowers the reimbursement for low-dose CT lung cancer screenings by 44 percent, from $112.49... […]
DIGNITY HEALTH and Catholic Health Initiatives announced the launch of the Precision Medicine Alliance LLC, which will offer patients from both health care systems faster and more accurate diagnostic and treatment protocols based on their genetic and molecular profile information.
